Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

NCT01554618 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

84

Enrollment

INDUSTRY

Sponsor class

Conditions

Children and Adolescent With Type 2 Diabetes

Interventions

DRUG: Exenatide Once Weekly
DRUG: Placebo

Sponsor

AstraZeneca